These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 24033910

  • 1. A multicenter, randomized, double-blinded, placebo-controlled phase III study of Clot Lysis Evaluation of Accelerated Resolution of Intraventricular Hemorrhage (CLEAR III).
    Ziai WC, Tuhrim S, Lane K, McBee N, Lees K, Dawson J, Butcher K, Vespa P, Wright DW, Keyl PM, Mendelow AD, Kase C, Wijman C, Lapointe M, John S, Thompson R, Thompson C, Mayo S, Reilly P, Janis S, Awad I, Hanley DF, CLEAR III Investigators.
    Int J Stroke; 2014 Jun; 9(4):536-42. PubMed ID: 24033910
    [Abstract] [Full Text] [Related]

  • 2. Permanent CSF shunting after intraventricular hemorrhage in the CLEAR III trial.
    Murthy SB, Awad I, Harnof S, Aldrich F, Harrigan M, Jallo J, Caron JL, Huang J, Camarata P, Lara LR, Dlugash R, McBee N, Eslami V, Hanley DF, Ziai WC, CLEAR III Trial Investigators.
    Neurology; 2017 Jul 25; 89(4):355-362. PubMed ID: 28659429
    [Abstract] [Full Text] [Related]

  • 3. A randomized 500-subject open-label phase 3 clinical trial of minimally invasive surgery plus alteplase in intracerebral hemorrhage evacuation (MISTIE III).
    Ziai WC, McBee N, Lane K, Lees KR, Dawson J, Vespa P, Thompson RE, Mendelow AD, Kase CS, Carhuapoma JR, Thompson CB, Mayo SW, Reilly P, Janis S, Anderson CS, Harrigan MR, Camarata PJ, Caron JL, Zuccarello M, Awad IA, Hanley DF, MISTIE III Investigators.
    Int J Stroke; 2019 Jul 25; 14(5):548-554. PubMed ID: 30943878
    [Abstract] [Full Text] [Related]

  • 4. Low-dose recombinant tissue-type plasminogen activator enhances clot resolution in brain hemorrhage: the intraventricular hemorrhage thrombolysis trial.
    Naff N, Williams MA, Keyl PM, Tuhrim S, Bullock MR, Mayer SA, Coplin W, Narayan R, Haines S, Cruz-Flores S, Zuccarello M, Brock D, Awad I, Ziai WC, Marmarou A, Rhoney D, McBee N, Lane K, Hanley DF.
    Stroke; 2011 Nov 25; 42(11):3009-16. PubMed ID: 21868730
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of combined intraventricular fibrinolysis with lumbar drainage for prevention of permanent shunt dependency after intracerebral hemorrhage with severe ventricular involvement: A randomized trial and individual patient data meta-analysis.
    Staykov D, Kuramatsu JB, Bardutzky J, Volbers B, Gerner ST, Kloska SP, Doerfler A, Schwab S, Huttner HB.
    Ann Neurol; 2017 Jan 25; 81(1):93-103. PubMed ID: 27888608
    [Abstract] [Full Text] [Related]

  • 6. Preliminary report of the clot lysis evaluating accelerated resolution of intraventricular hemorrhage (CLEAR-IVH) clinical trial.
    Morgan T, Awad I, Keyl P, Lane K, Hanley D.
    Acta Neurochir Suppl; 2008 Jan 25; 105():217-20. PubMed ID: 19066112
    [Abstract] [Full Text] [Related]

  • 7. Association Between Intraventricular Alteplase Use and Parenchymal Hematoma Volume in Patients With Spontaneous Intracerebral Hemorrhage and Intraventricular Hemorrhage.
    Witsch J, Roh DJ, Avadhani R, Merkler AE, Kamel H, Awad I, Hanley DF, Ziai WC, Murthy SB.
    JAMA Netw Open; 2021 Dec 01; 4(12):e2135773. PubMed ID: 34860246
    [Abstract] [Full Text] [Related]

  • 8. Effectiveness of Combined External Ventricular Drainage with Intraventricular Fibrinolysis for the Treatment of Intraventricular Haemorrhage with Acute Obstructive Hydrocephalus.
    Luong CQ, Nguyen AD, Nguyen CV, Mai TD, Nguyen TA, Do SN, Dao PV, Pham HTM, Pham DT, Ngo HM, Nguyen QH, Nguyen DT, Tran TH, Le KV, Do NT, Ngo ND, Nguyen VD, Ngo HD, Hoang HB, Vu HV, Vu LT, Ngo BT, Nguyen BX, Khuong DQ, Nguyen DT, Vuong TX, Be TH, Gaberel T, Nguyen LV.
    Cerebrovasc Dis Extra; 2019 Dec 01; 9(2):77-89. PubMed ID: 31408859
    [Abstract] [Full Text] [Related]

  • 9. Safety of intraventricular hemorrhage (IVH) thrombolysis based on CT localization of external ventricular drain (EVD) fenestrations and analysis of EVD tract hemorrhage.
    Jackson DA, Patel AV, Darracott RM, Hanel RA, Freeman WD, Hanley DF.
    Neurocrit Care; 2013 Aug 01; 19(1):103-10. PubMed ID: 22544476
    [Abstract] [Full Text] [Related]

  • 10. Effect of recombinant tissue plasminogen activator on clot lysis and ventricular dilatation in the treatment of severe intraventricular haemorrhage.
    Mayfrank L, Lippitz B, Groth M, Bertalanffy H, Gilsbach JM.
    Acta Neurochir (Wien); 1993 Aug 01; 122(1-2):32-8. PubMed ID: 8333306
    [Abstract] [Full Text] [Related]

  • 11. Resolution of intraventricular hemorrhage varies by ventricular region and dose of intraventricular thrombolytic: the Clot Lysis: Evaluating Accelerated Resolution of IVH (CLEAR IVH) program.
    Webb AJ, Ullman NL, Mann S, Muschelli J, Awad IA, Hanley DF.
    Stroke; 2012 Jun 01; 43(6):1666-8. PubMed ID: 22474059
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Minimally invasive evacuation of spontaneous intracerebral hemorrhage using sonothrombolysis.
    Newell DW, Shah MM, Wilcox R, Hansmann DR, Melnychuk E, Muschelli J, Hanley DF.
    J Neurosurg; 2011 Sep 01; 115(3):592-601. PubMed ID: 21663412
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of Volumetric Change of Intracerebral Hemorrhage in Patients Treated with Thrombolysis for Intraventricular Hemorrhage.
    Staub-Bartelt F, van Lieshout JH, Beez T, Kram R, Hänggi D, Beseoglu K.
    Neurocrit Care; 2021 Apr 01; 34(2):529-536. PubMed ID: 32737761
    [Abstract] [Full Text] [Related]

  • 15. One-Year Outcome Trajectories and Factors Associated with Functional Recovery Among Survivors of Intracerebral and Intraventricular Hemorrhage With Initial Severe Disability.
    Shah VA, Thompson RE, Yenokyan G, Acosta JN, Avadhani R, Dlugash R, McBee N, Li Y, Hansen BM, Ullman N, Falcone G, Awad IA, Hanley DF, Ziai WC.
    JAMA Neurol; 2022 Sep 01; 79(9):856-868. PubMed ID: 35877105
    [Abstract] [Full Text] [Related]

  • 16. Occurrence and impact of intracranial pressure elevation during treatment of severe intraventricular hemorrhage.
    Ziai WC, Melnychuk E, Thompson CB, Awad I, Lane K, Hanley DF.
    Crit Care Med; 2012 May 01; 40(5):1601-8. PubMed ID: 22430237
    [Abstract] [Full Text] [Related]

  • 17. Intraventricular thrombolysis after endovascular treatment of a ruptured arteriovenous malformation.
    Wang A, Ray A, Hu YC.
    J Neurointerv Surg; 2017 Feb 01; 9(2):e8. PubMed ID: 27251552
    [Abstract] [Full Text] [Related]

  • 18. Does stereotactic thrombolysis with alteplase for intracerebral haemorrhage alter intraventricular haematoma volume? A secondary analysis of the MISTIE-III trial.
    Sun P, Badihian S, Avadhani R, Walborn N, Yarava A, Alimoradi D, Awad I, Hanley D, Murthy S, Ziai W.
    J Neurol Neurosurg Psychiatry; 2024 Sep 17; 95(10):892-898. PubMed ID: 38670789
    [Abstract] [Full Text] [Related]

  • 19. Factors affecting clot lysis rates in patients with spontaneous intraventricular hemorrhage.
    Ziai WC, Muschelli J, Thompson CB, Keyl PM, Lane K, Shao S, Hanley DF.
    Stroke; 2012 May 17; 43(5):1234-9. PubMed ID: 22382155
    [Abstract] [Full Text] [Related]

  • 20. Third Ventricle Obstruction by Thalamic Intracerebral Hemorrhage Predicts Poor Functional Outcome Among Patients Treated with Alteplase in the CLEAR III Trial.
    Ullman NL, Tahsili-Fahadan P, Thompson CB, Ziai WC, Hanley DF.
    Neurocrit Care; 2019 Apr 17; 30(2):380-386. PubMed ID: 30251074
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.